From: Cost burden and net monetary benefit loss of neonatal hypoglycaemia
Single health-state outcomes: | Number of prevalence reportsa | Sum of cases | Sum of study populations | Weighted mean prevalence | Minimum prevalence | Maximum prevalence |
---|---|---|---|---|---|---|
Cerebral palsy | 53 | 1020 | 5.20% | 0.38% | 14.89% | |
Childhood epilepsies and convulsions | 7604 | 1,421,813 | 0.53% | 0.52% | 4.58% | |
Learning disabilities | 205 | 1314 | 15.60% | 2.38% | 54.00% | |
Severe learning disabilities | 1 [23] | 9 | 278 | 3.24% | 3.24% | 3.24% |
Vision disorders/blindness | 1 [23] | 2 | 270 | 0.74% | 0.74% | 0.74% |